$BSGM
BioSig Technologies, Inc.

2022 Q4 Form 10-Q Financial Statement

#000118518522001305 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $135.0K $135.0K $8.000K
YoY Change 1587.5% 25.0%
Cost Of Revenue $27.00K $30.00K $0.00
YoY Change -21.05%
Gross Profit $108.0K $105.0K $8.000K
YoY Change 1250.0% 50.0%
Gross Profit Margin 80.0% 77.78% 100.0%
Selling, General & Admin $5.903M $4.774M $7.597M
YoY Change -22.3% -26.61% -8.8%
% of Gross Profit 5465.74% 4546.67% 94962.5%
Research & Development $1.120M $1.700M $1.354M
YoY Change -17.28% 29.28% -47.52%
% of Gross Profit 1037.04% 1619.05% 16925.0%
Depreciation & Amortization $83.00K $84.00K $56.00K
YoY Change 48.21% 64.71% 180.0%
% of Gross Profit 76.85% 80.0% 700.0%
Operating Expenses $7.106M $6.591M $9.007M
YoY Change -21.11% -16.26% -17.59%
Operating Profit -$6.998M -$6.486M -$8.999M
YoY Change -22.24% -16.86%
Interest Expense $2.000K $1.000K $0.00
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.996M -$6.485M -$8.999M
YoY Change -22.26% -10.51% -17.67%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.045M -$6.372M -$8.644M
YoY Change -18.5% -12.15% -16.0%
Net Earnings / Revenue -5218.52% -4720.0% -108050.0%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$0.14 -$141.6K -$244.2K
COMMON SHARES
Basic Shares Outstanding 48.02M shares 44.81M shares
Diluted Shares Outstanding 45.02M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $458.0K $937.0K $11.66M
YoY Change -96.07% -94.66% -58.76%
Cash & Equivalents $400.0K $900.0K $11.66M
Short-Term Investments $101.0K $50.00K
Other Short-Term Assets $325.0K $456.0K $354.0K
YoY Change -8.19% -5.59% 18.0%
Inventory $336.0K $1.691M $1.881M
Prepaid Expenses $325.0K $456.0K $354.0K
Receivables $9.000K $5.000K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.128M $3.089M $13.89M
YoY Change -91.88% -84.55% -52.64%
LONG-TERM ASSETS
Property, Plant & Equipment $665.0K $685.0K $652.0K
YoY Change 1.99% -45.2% 8.67%
Goodwill
YoY Change
Intangibles $1.000K $1.00 $1.000K
YoY Change 0.0%
Long-Term Investments $120.0K $66.00K
YoY Change
Other Assets $44.00K $44.00K $42.00K
YoY Change 4.76% -52.17% -61.82%
Total Long-Term Assets $2.982M $1.926M $1.625M
YoY Change 83.51% 15.05% 54.76%
TOTAL ASSETS
Total Short-Term Assets $1.128M $3.089M $13.89M
Total Long-Term Assets $2.982M $1.926M $1.625M
Total Assets $4.110M $5.015M $15.52M
YoY Change -73.52% -76.86% -48.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.165M $2.438M $2.462M
YoY Change 28.55% -0.89% -51.15%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.261M $2.540M $2.576M
YoY Change 26.59% -1.21% -49.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $452.0K $536.0K $378.0K
YoY Change 19.58% 27.01%
Total Long-Term Liabilities $452.0K $536.0K $378.0K
YoY Change 19.58% 27.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.261M $2.540M $2.576M
Total Long-Term Liabilities $452.0K $536.0K $378.0K
Total Liabilities $3.713M $3.076M $2.954M
YoY Change 25.69% -10.35% -50.02%
SHAREHOLDERS EQUITY
Retained Earnings -$216.0M -$209.0M -$188.9M
YoY Change 14.32%
Common Stock $55.00K $46.00K $36.00K
YoY Change 52.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $313.0K $1.822M $12.24M
YoY Change
Total Liabilities & Shareholders Equity $4.110M $5.015M $15.52M
YoY Change -73.52% -76.86% -48.93%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$7.045M -$6.372M -$8.644M
YoY Change -18.5% -12.15% -16.0%
Depreciation, Depletion And Amortization $83.00K $84.00K $56.00K
YoY Change 48.21% 64.71% 180.0%
Cash From Operating Activities -$4.114M -$4.947M -$5.731M
YoY Change -28.21% -26.8% -6.05%
INVESTING ACTIVITIES
Capital Expenditures $58.00K -$50.00K -$144.0K
YoY Change -140.28% -76.85% 380.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$58.00K -$50.00K -$144.0K
YoY Change -59.72% -76.85% 380.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.642M 807.0K -1.000K
YoY Change -364300.0% -91.04% -100.06%
NET CHANGE
Cash From Operating Activities -4.114M -4.947M -5.731M
Cash From Investing Activities -58.00K -50.00K -144.0K
Cash From Financing Activities 3.642M 807.0K -1.000K
Net Change In Cash -530.0K -4.190M -5.876M
YoY Change -90.98% -306.3% 31.16%
FREE CASH FLOW
Cash From Operating Activities -$4.114M -$4.947M -$5.731M
Capital Expenditures $58.00K -$50.00K -$144.0K
Free Cash Flow -$4.172M -$4.897M -$5.587M
YoY Change -25.33% -25.15% -7.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38659
dei Entity Registrant Name
EntityRegistrantName
BIOSIG TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4333375
dei Entity Address Address Line1
EntityAddressAddressLine1
55 Greens Farms Road, 1st Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Westport
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06880
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
409-5444
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
BSGM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48020467 shares
CY2022Q3 us-gaap Cash
Cash
887000 usd
CY2021Q4 us-gaap Cash
Cash
11659000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1691000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1881000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
456000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
354000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
3089000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13894000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
685000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
652000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
819000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
66000 usd
CY2021Q4 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
0 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
312000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
326000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43000 usd
CY2022Q3 us-gaap Assets
Assets
5015000 usd
CY2021Q4 us-gaap Assets
Assets
15519000 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
107000 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
86000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2092000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2179000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32000 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
89000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
82000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
346000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
283000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2540000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2576000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
536000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
373000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
536000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
378000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3076000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2954000 usd
CY2022Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
105000 usd
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
105000 usd
CY2022Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
105 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
105 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
105 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
105 shares
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
105000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
105000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45797952 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45797952 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35567180 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35567180 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
210792000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
201127000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209016000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-188922000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1822000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12241000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
12000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
219000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1834000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12460000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5015000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15519000 usd
CY2022Q3 us-gaap Revenues
Revenues
135000 usd
CY2021Q3 us-gaap Revenues
Revenues
108000 usd
us-gaap Revenues
Revenues
151000 usd
us-gaap Revenues
Revenues
433000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
199000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
105000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
70000 usd
us-gaap Gross Profit
GrossProfit
121000 usd
us-gaap Gross Profit
GrossProfit
234000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1733000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1315000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4701000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4248000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4774000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6505000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15477000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20256000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
84000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
210000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
142000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6591000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7871000 usd
us-gaap Operating Expenses
OperatingExpenses
20388000 usd
us-gaap Operating Expenses
OperatingExpenses
24646000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6486000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7801000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20267000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24412000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
553000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
553000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6485000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7247000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20266000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23857000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6485000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7247000 usd
us-gaap Profit Loss
ProfitLoss
-20266000 usd
us-gaap Profit Loss
ProfitLoss
-23857000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-113000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-172000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-584000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6372000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7253000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20094000 usd
us-gaap Net Income Loss
NetIncomeLoss
-23273000 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
7000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
7000 usd
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
17000 usd
CY2021Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
125000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6391000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7255000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20226000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23280000 usd
CY2022Q3 bsgm Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.14
CY2021Q3 bsgm Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.21
bsgm Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.5
bsgm Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.71
CY2022Q3 bsgm Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
45015574 shares
CY2021Q3 bsgm Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
34856502 shares
bsgm Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
40311669 shares
bsgm Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
32881932 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12460000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1601000 usd
CY2022Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
15000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
3002000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-8065000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9410000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
483000 usd
CY2022Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
438000 usd
CY2022Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
2818000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-317000 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-5716000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6977000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
807000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
537000 usd
CY2022Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
17000 usd
CY2022Q3 bsgm Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
-17000 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6485000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1834000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25172000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1777000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
742000 usd
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8559000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20458000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140000 usd
CY2021Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
321000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1652000 usd
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-8051000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14517000 usd
CY2021Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
9005000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1354000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
948000 usd
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7247000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18575000 usd
us-gaap Profit Loss
ProfitLoss
-20266000 usd
us-gaap Profit Loss
ProfitLoss
-23857000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
210000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
142000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
244000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
334000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2703000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6613000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
553000 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
-15000 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
-321000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
50000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
114000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-70000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1113000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
104000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
117000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-24000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
45000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-87000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1999000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-233000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-334000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17591000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20668000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
398000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-398000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5820000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9005000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1109000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1300000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
28000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6929000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10333000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10772000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10733000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11659000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28268000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
887000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17535000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
7000 usd
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
7000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
502000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
800000 usd
CY2022Q3 bsgm Excise Tax Repurchases Of Stock Rate
ExciseTaxRepurchasesOfStockRate
0.01 pure
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
900000 usd
CY2022Q3 bsgm Working Capital Deficit
WorkingCapitalDeficit
500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of these unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4333 usd
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P30M
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2022Q3 bsgm Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
0.02 pure
bsgm Sales Type Lease Invoiced To Customer
SalesTypeLeaseInvoicedToCustomer
-13000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
478000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-433000 usd
CY2021Q3 us-gaap Policyholder Funds
PolicyholderFunds
45000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5000 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
13000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
37000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentrations of Credit Risk</i></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit. At September 30, 2022 and December 31, 2021, deposits in excess of FDIC limits were $0.06 million and $11.2 million, respectively.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
60000.00 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
11200000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
176000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1515000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1881000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1691000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1881000 usd
us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
0 usd
CY2022Q3 us-gaap Security Deposit
SecurityDeposit
43 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
42 usd
CY2022Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1 usd
CY2021Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
44 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
43 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1700000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4700000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1300000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4200000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8829876 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5102824 shares
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4751 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14254 usd
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4751 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14254 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1208000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
981000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
523000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
329000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
685000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
652000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
79312 usd
us-gaap Depreciation
Depreciation
195937 usd
CY2021Q3 us-gaap Depreciation
Depreciation
46205 usd
us-gaap Depreciation
Depreciation
128152 usd
CY2022Q2 us-gaap Security Deposit
SecurityDeposit
27404 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
42312 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
40564 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
502445 usd
bsgm Number Of Leases
NumberOfLeases
4 pure
CY2022Q3 bsgm Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
1087000 usd
CY2021Q4 bsgm Operating Lease Right To Use Assets Gross
OperatingLeaseRightToUseAssetsGross
803000 usd
CY2022Q3 bsgm Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
268000 usd
CY2021Q4 bsgm Operating Lease Right To Use Asset Accumulated Depreciation
OperatingLeaseRightToUseAssetAccumulatedDepreciation
199000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
819000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
116725 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
333071 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
120127 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
365366 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
882000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
656000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
346000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
283000 usd
CY2022Q3 us-gaap Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
114000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
536000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
373000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
98000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
393000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
370000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
106000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
967000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
85000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
882000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
78000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
105000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000 usd
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
15000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
29000 usd
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
117000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
120000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
244000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
334000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
28000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
31000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
61000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Lease Cost
LeaseCost
333000 usd
us-gaap Lease Cost
LeaseCost
365000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4333 usd
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P30M
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2022Q3 bsgm Lessor Sales Type Lease Discount Rate
LessorSalesTypeLeaseDiscountRate
0.02 pure
CY2022Q3 us-gaap Sales Type Lease Unguaranteed Residual Asset
SalesTypeLeaseUnguaranteedResidualAsset
2 usd
CY2021Q4 us-gaap Sales Type Lease Lease Receivable
SalesTypeLeaseLeaseReceivable
0 usd
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
127000 usd
CY2021Q4 bsgm Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
84000 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
505000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
13000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
52000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
52000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
117000 usd
CY2022Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
3000 usd
CY2022Q3 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
114000 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
319000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
204000 usd
CY2022Q3 bsgm Accrued Reimbursements Current
AccruedReimbursementsCurrent
51000 usd
CY2021Q4 bsgm Accrued Reimbursements Current
AccruedReimbursementsCurrent
56000 usd
CY2022Q3 bsgm Accrued Consulting Current
AccruedConsultingCurrent
225000 usd
CY2021Q4 bsgm Accrued Consulting Current
AccruedConsultingCurrent
264000 usd
CY2022Q3 bsgm Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
598000 usd
CY2021Q4 bsgm Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
367000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1000 usd
CY2022Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
268000 usd
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
38000 usd
CY2022Q3 bsgm Accrued Office Expense And Other Expense
AccruedOfficeExpenseAndOtherExpense
113000 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
552000 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
13000 usd
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
613000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2092000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2179000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
2.27
CY2022Q3 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
0.63
bsgm Deemed Preferred Stock Dividend
DeemedPreferredStockDividend
124953 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45797952 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35567180 shares
CY2022Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.9
CY2022Q2 bsgm At The Market Offering
AtTheMarketOffering
10000000 usd
CY2022Q2 bsgm Commission Rate
CommissionRate
0.025 pure
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1237226 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1108716 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
67130 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4735484 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2888670 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4568484 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.57
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1278000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.2
bsgm Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1111000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.69
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4735484 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2888670 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.82
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.87
CY2022Q1 bsgm Options Modified
OptionsModified
100000 shares
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
15181 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3649123 shares
CY2022Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
818910 shares
CY2021Q4 bsgm Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
5.74
CY2021 bsgm Warrants Outstanding Weighted Average Remaining Contractual Term
WarrantsOutstandingWeightedAverageRemainingContractualTerm
P5Y3M18D
bsgm Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
2830213 shares
bsgm Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Granted
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted
1.36
bsgm Warrants Granted Weighted Average Remaining Contractual Term
WarrantsGrantedWeightedAverageRemainingContractualTerm
P3Y4M24D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3649123 shares
CY2022Q3 bsgm Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
2.35
bsgm Warrants Outstanding Weighted Average Remaining Contractual Term
WarrantsOutstandingWeightedAverageRemainingContractualTerm
P3Y8M12D
CY2022Q3 bsgm Class Of Warrant Or Rights Vested And Expected To Vest Outstanding
ClassOfWarrantOrRightsVestedAndExpectedToVestOutstanding
3649123 shares
CY2022Q3 bsgm Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Vested And Expected To Vest Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsVestedAndExpectedToVestOutstanding
2.35
bsgm Warrants Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
WarrantsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
P3Y4M24D
CY2022Q3 bsgm Class Of Warrant Or Rights Exercisable
ClassOfWarrantOrRightsExercisable
3649123 shares
CY2022Q3 bsgm Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercisable
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable
2.35
bsgm Warrants Exercisable Weighted Average Remaining Contractual Term
WarrantsExercisableWeightedAverageRemainingContractualTerm
P3Y4M24D
CY2022Q3 us-gaap Share Price
SharePrice
0.64
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
the exercise price of an Incentive Stock Option should not be less than 110% of fair market value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair market value for a grantee who is not 10% stockholder
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2415074 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1078679 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1078679 shares
CY2021Q4 us-gaap Minority Interest
MinorityInterest
219000 usd
bsgm Allocation Of Equity To Noncontrolling Interest Due To Subsidiary Shares Issued In Settlement Of De
AllocationOfEquityToNoncontrollingInterestDueToSubsidiarySharesIssuedInSettlementOfDe
292000 usd
bsgm Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Due Change In Fair Value Of Modified Option
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesDueChangeInFairValueOfModifiedOption
-327000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-172000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
12000 usd
CY2022Q1 bsgm Monthly Service Fee
MonthlyServiceFee
40000 usd
CY2022Q1 bsgm Commission Rate
CommissionRate
0.10 pure
CY2022Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
41 usd
CY2021Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
0 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Central Index Key
EntityCentralIndexKey
0001530766
CY2017Q1 bsgm Agreement Term
AgreementTerm
P10Y
CY2019Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
700000 usd
CY2021 us-gaap Payments For Royalties
PaymentsForRoyalties
75000 usd
CY2019Q4 bsgm Royalty Percentage Of Net Sales
RoyaltyPercentageOfNetSales
0.10 pure
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
57044 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
192572 usd
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
61313 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
189740 usd
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
2366375 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 pure
CY2022Q3 us-gaap Revenues
Revenues
135000 usd
CY2021Q3 us-gaap Revenues
Revenues
108000 usd
us-gaap Revenues
Revenues
151000 usd
us-gaap Revenues
Revenues
433000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6591000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7871000 usd
us-gaap Operating Expenses
OperatingExpenses
20388000 usd
us-gaap Operating Expenses
OperatingExpenses
24646000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6486000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7801000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20267000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24412000 usd
CY2022Q3 us-gaap Assets
Assets
5015000 usd
CY2021Q4 us-gaap Assets
Assets
15519000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
106659 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
86208 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
vesting over monthly over six months from the date of grant
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3

Files In Submission

Name View Source Status
0001185185-22-001305-index-headers.html Edgar Link pending
0001185185-22-001305-index.html Edgar Link pending
0001185185-22-001305.txt Edgar Link pending
0001185185-22-001305-xbrl.zip Edgar Link pending
biosig20220930_10q.htm Edgar Link pending
bsgm-20220930.xsd Edgar Link pending
ex_444915.htm Edgar Link pending
ex_444916.htm Edgar Link pending
ex_444917.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
biosig20220930_10q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bsgm-20220930_cal.xml Edgar Link unprocessable
bsgm-20220930_lab.xml Edgar Link unprocessable
bsgm-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bsgm-20220930_pre.xml Edgar Link unprocessable